E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 1/15/2008 in the Prospect News Special Situations Daily.

Radiation Therapy sets meeting date for merger vote

By Lisa Kerner

Charlotte, N.C., Jan. 15 - Shareholders of Radiation Therapy Services, Inc. will vote on the company's merger with Vestar Capital Partners on Feb. 6 at 10 a.m. ET in Bonita Springs, Fla.

The record date for the meeting is Jan. 10, according to a schedule 14A filing with the Securities and Exchange Commission.

Under the companies' Oct. 19 merger agreement, Vestar will acquire Radiation Therapy for $32.50 per share in a deal valued at $1.1 billion including debt.

It was previously reported that Radiation Therapy chief executive officer Daniel Dosoretz, along with other members of senior management owning some 40% of the company, agreed to vote their shares in favor of the merger.

Radiation Therapy operates radiation treatment centers primarily under the name 21st Century Oncology. The company is based in Fort Myers, Fla.

Vestar Capital Partners is a private equity firm with offices in New York and other cities.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.